Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine

Status unconfirmed · Phase 1

Conditions studied: Pharmacokinetics

In brief

This is an open label, single-center study to determine whether certain nasal medication interact with PMI-150 (intranasal ketamine) 30 mg in healthy adult volunteers and in patients with allergic rhinitis.

Key facts

Study ID

NCT00520104

Run by

Javelin Pharmaceuticals

People needed

48

Starts

2007-08-01

Expected to finish

2008-03-01

Last updated by the study team

2008-02-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy adults
• Patients with Allergic Rhinitis

You may not qualify if…

• Under age 18

Where it is running

• Javelin Pharmaceuticals — Cambridge, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.